Faculty

Institution

Unit

Venue

Ellie S. Sukerman, M.D.

Associate Professor of Medicine Division of Infectious Diseases School of Medicine Medical Director Antimicrobial Stewardship OHSU and Hillsboro Medical Center

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Department Of Medicine

Infectious Diseases

Ellie S. Sukerman, M.d. is currently serving as a Medicine Associate Professor of Medicine Division of Infectious Diseases School of Medicine Medical Director Antimicrobial Stewardship OHSU and Hillsboro Medical Center at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ellie S. Sukerman, M.D.

Oregon Health & Science University

Associate Professor of Medicine Division of Infectious Diseases School of Medicine Medical Director Antimicrobial Stewardship OHSU and Hillsboro Medical Center

You can click a keyword to filter the displayed items

antibiotics medicine infection control antimicrobial resistance infectious diseases antimicrobial agents hospital infections drug allergy antimicrobial stewardship allergy infectious diseases (medical specialty) pharmacotherapy healthcare-associated infections orthopaedic surgery clinical microbiology virology drug resistance applied pharmacology antibiotic adjuvant clinical infectious disease spinal disorders antimicrobial chemotherapy heart transplantation vertebral osteomyelitis proteomics influenza asthma virus research internal medicine arthritis communicable diseases medical virology transplant infectious diseases clinical transplantation spinal cord medicine addiction medicine substance use vaccine development solid organ transplantation transplantation medicine antibiotic resistance drug safety pharmacokinetics therapeutic drug monitoring drug assessment pharmacoepidemiology skin testing skin allergies clinical pharmacy antimicrobial susceptibility hospital epidemiology pan-viral host targets oral antibiotic therapy joint infections other antibiotic allergies dalba got back hidden cost opat rn time dalbavancin use heart transplant recipients risk factors response rate staphylococcus aureus heart transplant candidates oral antibiotic use hospital readmission

Notable Scholarly Works

Notable Federal Grants

Collaborators

P-830. Comparison of Oral Antibiotic Use and Hospital Readmission Among People Who Use Drugs With Staphylococcus Aureus Bacteremia and Before Medically Advised Discharge During Two Time Periods. Open Forum Infectious Diseases (2025)

antimicrobial agentsmedicineantimicrobial resistanceantimicrobial stewardshippatient safetyinfection controlemergency medicineclinical microbiologyantimicrobial susceptibilityantibioticshospital infectionshospital epidemiologyhealthcare-associated infectionsoral antibiotic usetime periodshospital readmission

Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis. Open Forum Infectious Diseases (2024)

surgerybone fracturemedicinepain managementvertebral osteomyelitisspinal cord medicinedalba got backantibioticsclinical researchorthopedic surgeryspinal disordersorthopaedic surgery

Proteomic and Genetic Analyses of Influenza a Viruses Identify Pan-Viral Host Targets. Nature Communications (2023)

Kelsey M. HaasMichael J. McGregorMehdi BouhaddouBenjamin J. PolaccoEun-Young KimThong T. NguyenBilly W. NewtonMatthew UrbanowskiHeejin KimMichael A. P. WilliamsVeronica V. RezeljAlexandra HardyAndrea FossatiErica J. StevensonEllie SukermanTiffany KimSudhir PenugondaElena MorenoHannes BrabergYuan ZhouGiorgi MetreveliBhavya HarjaiTia A. TumminoJames E. MelnykMargaret SoucherayJyoti BatraLars PacheLaura Martin-SanchoJared Carlson-StevermerAlexander S. JurekaChristopher F. BaslerKevan M. ShokatBrian K. ShoichetLeah P. ShriverJeffrey R. JohnsonMegan L. ShawSumit K. ChandaDan M. RodenTonia C. CarterLeah C. KottyanRex L. ChisholmJennifer A. PachecoMaureen E. SmithSteven J. SchrodiRandy A. AlbrechtMarco VignuzziLorena Zuliani-AlvarezDanielle L. SwaneyManon EckhardtSteven M. WolinskyKris M. WhiteJudd F. HultquistRobyn M. KaakeAdolfo García-SastreNevan J. Krogan

immunologyvirus researchproteomicspan-viral host targetsvirologyinfluenza

The Hidden Cost of Dalbavancin: Opat Rn Time Required in Coordination for Persons Who Use Drugs. Therapeutic Advances in Infectious Disease (2023)

hidden costmedicinedrug safetypharmacologytherapeutic drug monitoringpharmacokineticsdrug metabolismpharmacotherapyapplied pharmacologydrug resistanceantibioticsopat rn time

Utility of Beta-Lactam Allergy Assessment in Patients Receiving Vancomycin for Surgical Prophylaxis. Surgery in Practice and Science (2023)

medicineoutcomes researchantimicrobial stewardshippatient safetydrug allergypharmacotherapyantibioticsanesthesiaclinical research

975. Dalbavancin for the Treatment of Vertebral Osteomyelitis. Open Forum Infectious Diseases (2022)

vertebral osteomyelitismedicinepain managementantibiotic adjuvantpain medicinepharmacotherapyantibioticsclinical researchorthopedic surgeryspinal disordersorthopaedic surgeryantimicrobial chemotherapy

Case Report: Persistent Shedding of a Live Vaccine-Derived Rubella Virus in a Young Man With Severe Combined Immunodeficiency and Cutaneous Granuloma. Frontiers in Immunology (2022)

communicable diseasesmedical virologyinfection controlvaccine developmentvirologyinfectious diseasesimmunity (medicine)

Delabeling Penicillin and Other Antibiotic Allergies in Solid Organ Transplantation Patients. Transplant Infectious Disease (2022)

Young Yoon HamShyam JoshiEllie Sukerman

clinical microbiologysolid organ transplantationinfectious diseasesantimicrobial resistanceantibiotic resistanceallergyantibioticspathogenic bacteriahospital infectionsother antibiotic allergiesdrug allergytransplant infectious diseasestransplantation medicineclinical infectious diseaseorgan transplantationinfection controldrug resistanceclinical transplantationmicrobiology

Evaluation of Opportunities for Oral Antibiotic Therapy in Bone and Joint Infections. Annals of Pharmacotherapy (2022)

arthritisantimicrobial agentsmedicineantimicrobial resistanceantimicrobial stewardshipjoint infectionsinfection controlantibiotic adjuvantantibioticsorthopaedic surgeryoral antibiotic therapyinfectious diseases (medical specialty)

1093. Bypassing Penicillin Skin Testing in Favor of Direct Oral Challenge: A Pharmacy-Driven Inpatient Program. Open Forum Infectious Diseases (2021)

antimicrobial agentsmedicineantimicrobial resistanceantimicrobial stewardshipinfection controlvenereologyclinical pharmacyhealthcare-associated infectionsantibioticsclinical trialshospital infectionsinfectious diseasesinfectious diseases (medical specialty)clinical infectious disease

1
2
10 / page

Ellie S. Sukerman, M.D.

Associate Professor of Medicine Division of Infectious Diseases School of Medicine Medical Director Antimicrobial Stewardship OHSU and Hillsboro Medical Center

Oregon Health & Science University

Affiliations

OHSU School of Medicine

Department Of Medicine

Infectious Diseases

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ellie S. Sukerman, M.D.

Oregon Health & Science University

Associate Professor of Medicine Division of Infectious Diseases School of Medicine Medical Director Antimicrobial Stewardship OHSU and Hillsboro Medical Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Dalba Got Back? Use of Dalbavancin for the Treatment of Vertebral Osteomyelitis. Open Forum Infectious Diseases (2024)

surgerybone fracturemedicinepain managementvertebral osteomyelitisspinal cord medicinedalba got backantibioticsclinical researchorthopedic surgeryspinal disordersorthopaedic surgery

Proteomic and Genetic Analyses of Influenza a Viruses Identify Pan-Viral Host Targets. Nature Communications (2023)

immunologyvirus researchproteomicspan-viral host targetsvirologyinfluenza

The Hidden Cost of Dalbavancin: Opat Rn Time Required in Coordination for Persons Who Use Drugs. Therapeutic Advances in Infectious Disease (2023)

hidden costmedicinedrug safetypharmacologytherapeutic drug monitoringpharmacokineticsdrug metabolismpharmacotherapyapplied pharmacologydrug resistanceantibioticsopat rn time

Utility of Beta-Lactam Allergy Assessment in Patients Receiving Vancomycin for Surgical Prophylaxis. Surgery in Practice and Science (2023)

medicineoutcomes researchantimicrobial stewardshippatient safetydrug allergypharmacotherapyantibioticsanesthesiaclinical research

975. Dalbavancin for the Treatment of Vertebral Osteomyelitis. Open Forum Infectious Diseases (2022)

Case Report: Persistent Shedding of a Live Vaccine-Derived Rubella Virus in a Young Man With Severe Combined Immunodeficiency and Cutaneous Granuloma. Frontiers in Immunology (2022)

communicable diseasesmedical virologyinfection controlvaccine developmentvirologyinfectious diseasesimmunity (medicine)

Delabeling Penicillin and Other Antibiotic Allergies in Solid Organ Transplantation Patients. Transplant Infectious Disease (2022)

Young Yoon HamShyam JoshiEllie Sukerman

Evaluation of Opportunities for Oral Antibiotic Therapy in Bone and Joint Infections. Annals of Pharmacotherapy (2022)

1093. Bypassing Penicillin Skin Testing in Favor of Direct Oral Challenge: A Pharmacy-Driven Inpatient Program. Open Forum Infectious Diseases (2021)

1
2
10 / page